IBB — iShares Biotechnology ETF price, holdings and performance

iShares Biotechnology ETF

iShares Biotechnology ETF (NASDAQ: IBB) is an exchange-traded fund. QuoTrend tracks its price, holdings, performance, fund flows and news.

Latest market price
199.39
+1.68+0.85%
OverviewShort InterestFilings
IBBiShares Biotechnology ETF·NASDAQ
199.39+0.85%
TA
Loading chart...
Screen all →
VXUS-0.40%$86.86VUG-0.31%$89.12VTV+0.31%$225.01VO+0.11%$82.78VB-0.24%$305.37VGT-0.56%$120.77VWO-0.21%$60.34SPCK+0.36%$22.10
Fund Snapshot
Category-Asset TypeEquityTagshealthcareReturn% 1Y51.05%Total Holdings247Perf Week6.06%
SponsorISharesETF TypeTagssectorReturn% 3Y16.26%AUM$9.47BPerf Month0.19%
Fund FamilyBond TypeTags-Return% 5Y3.85%NAV/shPerf Quarter16.23%
Index-Average MaturityTags-Return% 10Y52W High200.73 -0.67%Perf Half Y16.27%
Index WeightingCommodity TypeTags-Return% SI52W Low131.36 51.79%Perf YTD17.15%
Active/PassiveQuant TypeTags-Flows% 1M1.44%Volatility1.81% 1.88%Perf Year50.36%
Dividend TTM0.41 (0.21%)ESG TypeTags-Flows% 3M9.73%ATR (14)3.79Perf 3Y55.24%
Dividend Ex-DateJun 15, 2026Dividend TypeSector/ThemeFlows% YTD13.34%RSI (14)66.39Perf 5Y19.26%
Dividend Gr. 3/5Y-Structure TypeRegionFlows% 1YBeta0.70Perf 10Y106.18%
Expense0.44%Growth/ValueSMA204.34%Flows% 3YRel Volume0.97Prev Close197.71
Inverse/LeveragedMarket CapSMA507.90%Flows% 5YAvg Volume1.57MPrice199.39
IPO DateFeb 05, 2001Option/ShortYes / YesSMA20014.57%52W Range %98%Volume1,518,282Change0.85%
Assets Under Management
02.50B5.00B7.50B10.00B'24AprJunAugOct'25MarMayJulSepNov'26MarMayJul
● Assets Under Management
Latest News
Aug-07-26
Aug-07-2601:15AM
These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocksbarrons.com
Aug-05-26
Aug-05-2605:47AM
Moderna Advances Ebola Vaccine Into Human TestingBenzinga
Jul-30-26
Jul-30-2612:28AM
Nikkei 225, Kospi jolt Asian markets as AI rout and Fed fears collideinvezz.com
Jul-29-26
Jul-29-2611:58PM
Health Care's Clean Bill Of BreadthSeekingAlpha
Jul-28-26
Jul-28-2603:14AM
Cetera Investment Advisers Buys 10,994 Shares of iShares Biotechnology ETF $IBBdefenseworld.net
Jul-27-26
Jul-27-2607:25AM
FBT and IBB Are Not the Same Biotech Bet, and 5 Years of Returns Prove It247wallst.com
Jul-25-26
Jul-25-2608:25AM
Healthcare Systems' Liquidity ChallengeSeekingAlpha
Jul-23-26
Jul-23-2603:15PM
Playing The Biotech Breakout With Insidersseekingalpha.com
07:49AM
Which iShares Healthcare ETF Is the Better Buy: Diversified IXJ or Biotech-Focused IBB?fool.com
Jul-22-26
Jul-22-2612:32AM
Kospi jumps 6% as Asia's battered semiconductor trade reboundsinvezz.com
Jul-21-26
Jul-21-2603:01PM
Buying Biotech's Policy Discount With XBI And IBB: Most 'Feared' Nation Policy, Less-Than-Feared DamageSeekingAlpha
Jul-18-26
Jul-18-2601:03PM
AI Bubble Risks Make Dividend Stocks Attractive Againseekingalpha.com
Jul-14-26
Jul-14-2603:06PM
SELLAS Life Sciences: Strong Buy-Imminent Catalyst, Dual-Platform Pipeline, And A Market That Hasn't Caught UpSeekingAlpha
Jul-12-26
Jul-12-2603:30PM
Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance?fool.com
Jul-10-26
Jul-10-2606:41AM
IHE vs. IBB: Which iShares Healthcare ETF Is the Better Buy?fool.com
Fund

The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector.

Ownership

Per-holder 13F data isn't yet ingested for ETFs — coming with the next data layer expansion. Aggregate ownership shown above.

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR